Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study by Marina Rezende de Fázio, Marina Pontello Cristelli, Jane Tomimori, Carlos Eiji Koga, Marília Marufuji Ogawa, Giovanni Tani Beneventi, Helio Tedesco-Silva, José Medina-Pestana

Get full text